RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Daily Briefing

Charted: The risks of Covid-19—by age and vaccine brand


Unvaccinated people are significantly more likely to test positive for Covid-19 and to die from the disease than those who have been vaccinated, according to recent data released by CDC.

Your top resources on the Covid-19 vaccines

    Covid-19 risk by age, vaccine type

    CDC analyzed data from 16 public health departments, which includes information on roughly 30% of the U.S. population and covers the period from April through the end of August.

    Overall, CDC found that unvaccinated people are six times as likely to develop Covid-19 and 11 times as likely to die of the disease than those who are vaccinated.

    Age also remains a significant risk factor for severe cases of Covid-19. CDC found that vaccinated people who are ages 80 or higher are still at a higher risk of dying from Covid-19 than vaccinated or unvaccinated people under the age of 50.

    The data confirmed that all three vaccines that are authorized in the United States—manufactured by Johnson & Johnson (J&J), Moderna, and Pfizer-BioNTech—dramatically reduced both infections and deaths from Covid-19. The mRNA-based vaccines from Moderna and Pfizer-BioNTech appeared to provide the strongest protection.

    In a tweet, Celine Gounder, an infectious diseases expert at New York University, said CDC's data shows a "compelling" reason for allowing recipients of the J&J vaccine to receive an additional dose. (Carbajal, Becker's Hospital Review, 10/18; Owens, Axios, 10/19; Owens, Axios, 10/18; Sullivan, The Hill, 10/15)


    SPONSORED BY

    INTENDED AUDIENCE

    AFTER YOU READ THIS

    AUTHORS

    TOPICS

    INDUSTRY SECTORS

    MORE FROM TODAY'S DAILY BRIEFING

    Don't miss out on the latest Advisory Board insights

    Create your free account to access 1 resource, including the latest research and webinars.

    Want access without creating an account?

       

    You have 1 free members-only resource remaining this month.

    1 free members-only resources remaining

    1 free members-only resources remaining

    You've reached your limit of free insights

    Become a member to access all of Advisory Board's resources, events, and experts

    Never miss out on the latest innovative health care content tailored to you.

    Benefits include:

    Unlimited access to research and resources
    Member-only access to events and trainings
    Expert-led consultation and facilitation
    The latest content delivered to your inbox

    You've reached your limit of free insights

    Become a member to access all of Advisory Board's resources, events, and experts

    Never miss out on the latest innovative health care content tailored to you.

    Benefits include:

    Unlimited access to research and resources
    Member-only access to events and trainings
    Expert-led consultation and facilitation
    The latest content delivered to your inbox
    AB
    Thank you! Your updates have been made successfully.
    Oh no! There was a problem with your request.
    Error in form submission. Please try again.